Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 27-Feb-24 6:59 PM View:  | Exelixis, Inc. (EXEL) | 23-Feb-24 | Grant | 82,121 | -- | -- | 34% 240.0K to 322.12K | |
| 25-Aug-23 7:40 PM View: | Exelixis, Inc. (EXEL) | 24-Aug-23 | Grant | 240,000 | -- | -- | 100% 0 to 240.0K | |
| 20-Mar-23 6:43 PM View: | Cytomx Therapeutics, Inc. (CTMX) | 16-Mar-23 | Sale | 4,257 | $1.98 | $8,424.60 | (7%) 62.69K to 58.43K | |
| 21-Jul-22 4:11 PM View: | Cytomx Therapeutics, Inc. (CTMX) | 20-Jul-22 | Sale | 7,463 | $1.42 | $10,612.40 | (11%) 70.15K to 62.69K | |
| 21-Jul-22 4:11 PM View: | Cytomx Therapeutics, Inc. (CTMX) | 19-Jul-22 | Grant | 20,000 | -- | -- | 40% 50.15K to 70.15K | |
| 04-Feb-22 4:53 PM View: | Cytomx Therapeutics, Inc. (CTMX) | 02-Feb-22 | Grant | 40,000 | -- | -- | 623% 6.42K to 46.42K | |
| 08-Jun-21 1:07 PM View: | Cytomx Therapeutics, Inc. (CTMX) | 31-May-21 | Grant | 3,320 | $6.09 | $20,205.50 | 107% 3.1K to 6.42K | |
| 07-Dec-20 4:59 PM View: | Cytomx Therapeutics, Inc. (CTMX) | 30-Nov-20 | Grant | 3,101 | $6.39 | $19,821.60 | 100% 0 to 3.1K | |
| 19-Dec-18 6:34 PM View: | Beigene, Ltd. (BGNE) | 18-Dec-18 | Option Exercise | 10,141 | $29.10 | $295,103.00 | 5% 194.57K to 204.71K | |
| 19-Dec-18 6:34 PM View: | Beigene, Ltd. (BGNE) | 18-Dec-18 | Market Option Sale (Planned) | 10,141 | $133.74 | $1,356,310.00 | (5%) 204.71K to 194.57K | (95%) |
| 19-Dec-18 6:34 PM View: | Beigene, Ltd. (BGNE) | 17-Dec-18 | Option Exercise | 9,859 | $29.10 | $286,897.00 | 5% 194.57K to 204.43K | |
| 19-Dec-18 6:34 PM View: | Beigene, Ltd. (BGNE) | 17-Dec-18 | Market Option Sale (Planned) | 9,859 | $133.61 | $1,317,220.00 | (5%) 204.43K to 194.57K | (96%) |
| 13-Nov-18 10:20 AM View: | Beigene, Ltd. (BGNE) | 12-Nov-18 | Option Exercise | 12,067 | $29.10 | $351,150.00 | 6% 194.57K to 206.64K | |
| 13-Nov-18 10:20 AM View: | Beigene, Ltd. (BGNE) | 12-Nov-18 | Market Option Sale (Planned) | 12,067 | $112.73 | $1,360,350.00 | (6%) 206.64K to 194.57K | (132%) |
| 13-Nov-18 10:20 AM View: | Beigene, Ltd. (BGNE) | 09-Nov-18 | Option Exercise | 13,222 | $29.10 | $384,760.00 | 7% 194.57K to 207.79K | |
| 13-Nov-18 10:20 AM View: | Beigene, Ltd. (BGNE) | 09-Nov-18 | Market Option Sale (Planned) | 13,222 | $120.49 | $1,593,160.00 | (6%) 207.79K to 194.57K | (117%) |
| 13-Nov-18 10:20 AM View: | Beigene, Ltd. (BGNE) | 08-Nov-18 | Option Exercise | 14,711 | $29.10 | $428,090.00 | 8% 194.57K to 209.28K | |
| 13-Nov-18 10:20 AM View: | Beigene, Ltd. (BGNE) | 08-Nov-18 | Market Option Sale (Planned) | 14,711 | $126.07 | $1,854,580.00 | (7%) 209.28K to 194.57K | (107%) |
| 24-Aug-18 4:25 PM View: | Beigene, Ltd. (BGNE) | 23-Aug-18 | Market Sale (Planned) | 5,769 | $169.12 | $975,666.00 | (3%) 200.34K to 194.57K | (55%) |
| 28-Jun-18 7:41 PM View: | Beigene, Ltd. (BGNE) | 26-Jun-18 | Grant | 44,564 | -- | -- | 20% 225.0K to 269.57K | |
| 15-Nov-17 8:11 PM View: | Beigene, Ltd. (BGNE) | 13-Nov-17 | Market Sale (Planned) | 3,601 | $82.96 | $298,747.00 | (2%) 228.6K to 225.0K | (215%) |
| 24-Aug-17 4:20 PM View: | Beigene, Ltd. (BGNE) | 22-Aug-17 | Payment of Exercise | 28,185 | $5.39 | $151,830.00 | (9%) 300.0K to 271.81K | |
| 24-Aug-16 6:12 PM View: | Beigene, Ltd. (BGNE) | 22-Aug-16 | Grant | 300,000 | -- | -- | 100% 0 to 300.0K |